Therapeutic Failure in a Renal Transplant Patient with Pneumocystis Jiroveci Pneumonia: A Case Report

dc.contributor.authorArchontoulis, Nikolaos K.
dc.contributor.authorStaikou, Chryssoula V.
dc.date.accessioned2025-12-09T09:22:32Z
dc.date.issued2009-06
dc.description.abstractObjectives: Pneumocystis jiroveci pneumonia is common in immunocompromised individuals. Patients: This case report describes an immuno­suppressed patient who acquired P jiroveci pneumonia 6 months after renal transplant surgery. Results: The patient experienced many pneumonia-related complications and adverse effects from drug therapy, and despite treatment with various antibiotic agents, he died on the 62nd day after his admission to the intensive care unit. Conclusions: The therapeutic failure of the drug of choice (co-trimoxazole) was evident. This case raises questions about the development of P jiroveci resistance to current therapies.
dc.identifier.citationExperimental and Clinical Transplantation, Cilt, 7, Sayı, 2, 2009 ss. 129-132en
dc.identifier.eissn2146-8427en
dc.identifier.issn1304-0855
dc.identifier.issue2en
dc.identifier.urihttps://hdl.handle.net/11727/14082
dc.identifier.volume7en
dc.language.isoen_US
dc.publisherBaşkent Üniversitesi
dc.sourceExperimental and Clinical Transplantationen
dc.subjectRenal transplant
dc.subjectImmunosuppression
dc.subjectAntibiotics
dc.subjectTreatment
dc.subjectResistance
dc.titleTherapeutic Failure in a Renal Transplant Patient with Pneumocystis Jiroveci Pneumonia: A Case Report
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
129.pdf
Size:
111.23 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: